Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

Europe - OSL:CRAYN - NO0010808892 - Common Stock

144 NOK
-0.5 (-0.35%)
Last: 7/2/2025, 7:00:00 PM
Fundamental Rating

5

CRAYN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 103 industry peers in the Software industry. CRAYN scores excellent on profitability, but there are concerns on its financial health. CRAYN is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
In the past year CRAYN had a positive cash flow from operations.
Of the past 5 years CRAYN 4 years were profitable.
In the past 5 years CRAYN always reported a positive cash flow from operatings.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

CRAYN has a Return On Assets (1.53%) which is in line with its industry peers.
With a decent Return On Equity value of 10.80%, CRAYN is doing good in the industry, outperforming 66.35% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.88%, CRAYN belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
CRAYN had an Average Return On Invested Capital over the past 3 years of 8.15%. This is below the industry average of 12.80%.
The last Return On Invested Capital (11.88%) for CRAYN is above the 3 year average (8.15%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROIC 11.88%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

With a Profit Margin value of 4.12%, CRAYN perfoms like the industry average, outperforming 55.77% of the companies in the same industry.
CRAYN's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.00%, CRAYN is in the better half of the industry, outperforming 66.35% of the companies in the same industry.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
CRAYN has a better Gross Margin (89.27%) than 88.46% of its industry peers.
In the last couple of years the Gross Margin of CRAYN has grown nicely.
Industry RankSector Rank
OM 11%
PM (TTM) 4.12%
GM 89.27%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRAYN is creating some value.
CRAYN has more shares outstanding than it did 1 year ago.
CRAYN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CRAYN has been reduced compared to a year ago.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.02, we must say that CRAYN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CRAYN (1.02) is worse than 70.19% of its industry peers.
CRAYN has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
CRAYN has a better Debt to FCF ratio (1.61) than 75.96% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that CRAYN is somewhat dependend on debt financing.
CRAYN's Debt to Equity ratio of 0.58 is on the low side compared to the rest of the industry. CRAYN is outperformed by 62.50% of its industry peers.
Although CRAYN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Altman-Z 1.02
ROIC/WACC1.23
WACC9.67%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.98 indicates that CRAYN may have some problems paying its short term obligations.
CRAYN has a worse Current ratio (0.98) than 67.31% of its industry peers.
A Quick Ratio of 0.98 indicates that CRAYN may have some problems paying its short term obligations.
CRAYN's Quick ratio of 0.98 is on the low side compared to the rest of the industry. CRAYN is outperformed by 66.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.17% over the past year.
Measured over the past years, CRAYN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.95% on average per year.
Looking at the last year, CRAYN shows a small growth in Revenue. The Revenue has grown by 7.67% in the last year.
The Revenue for CRAYN have been decreasing by -12.43% on average. This is quite bad
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%

3.2 Future

The Earnings Per Share is expected to grow by 48.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, CRAYN will show a decrease in Revenue. The Revenue will decrease by -1.25% on average per year.
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.29, which means the current valuation is very expensive for CRAYN.
Compared to the rest of the industry, the Price/Earnings ratio of CRAYN indicates a somewhat cheap valuation: CRAYN is cheaper than 74.04% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of CRAYN to the average of the S&P500 Index (27.20), we can say CRAYN is valued slightly more expensively.
The Price/Forward Earnings ratio is 13.49, which indicates a correct valuation of CRAYN.
Based on the Price/Forward Earnings ratio, CRAYN is valued cheaper than 86.54% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, CRAYN is valued a bit cheaper.
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRAYN indicates a somewhat cheap valuation: CRAYN is cheaper than 73.08% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CRAYN is valued cheaply inside the industry as 91.35% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 11.79
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRAYN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRAYN's earnings are expected to grow with 48.55% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y65.95%
EPS Next 3Y48.55%

0

5. Dividend

5.1 Amount

CRAYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (7/2/2025, 7:00:00 PM)

144

-0.5 (-0.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-27 2025-08-27
Inst Owners59.97%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap12.90B
Analysts76
Price Target144.46 (0.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.25%
Min EPS beat(2)-60.61%
Max EPS beat(2)-37.9%
EPS beat(4)0
Avg EPS beat(4)-35.83%
Min EPS beat(4)-60.61%
Max EPS beat(4)-13.94%
EPS beat(8)2
Avg EPS beat(8)-24.98%
EPS beat(12)2
Avg EPS beat(12)-66.98%
EPS beat(16)5
Avg EPS beat(16)-94.94%
Revenue beat(2)0
Avg Revenue beat(2)-8.54%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-7.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.68%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-4.06%
Revenue beat(8)3
Avg Revenue beat(8)-3.98%
Revenue beat(12)5
Avg Revenue beat(12)-13.42%
Revenue beat(16)5
Avg Revenue beat(16)-31.36%
PT rev (1m)0%
PT rev (3m)0.55%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-1.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
P/S 1.81
P/FCF 11.23
P/OCF 9.75
P/B 4.76
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)4.08
EY2.83%
EPS(NY)10.68
Fwd EY7.41%
FCF(TTM)12.83
FCFY8.91%
OCF(TTM)14.77
OCFY10.26%
SpS79.49
BVpS30.28
TBVpS-11.43
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROCE 17.55%
ROIC 11.88%
ROICexc 17.65%
ROICexgc N/A
OM 11%
PM (TTM) 4.12%
GM 89.27%
FCFM 16.14%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Debt/EBITDA 1.4
Cap/Depr 50.58%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 117.39%
Profit Quality 392.15%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.02
F-Score6
WACC9.67%
ROIC/WACC1.23
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%
EBIT growth 1Y72.09%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year56.93%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y231.56%
FCF growth 3YN/A
FCF growth 5Y59.47%
OCF growth 1Y165.01%
OCF growth 3Y272.45%
OCF growth 5Y47.49%